Nasdaq · CIK 0001816736
IRON Disc Medicine, Inc.
A
95 / 100
Material weaknesses
1
Restatements
0
Auditor changes
0
Late filings
0
Quarters with open weakness
1
Remediations
1
Deductions
20
Remediation credit
15
Trailing 24 months from 2024-11-07. Rubric v1. How this is scored.
Disclosures, in the company's words
“our management concluded that these control deficiencies constituted a material weakness and that our internal control over financial reporting was not effective as of December 31, 2024.”
“As disclosed under Item 9A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, we previously identified a material weakness in internal controls related to a lack of design and maintenance of effective Information Technology General Controls, or ITGCs, over certain key financial IT systems.”
Remediation disclosed
- 10-Q · filed 2026-11-05 · source filing ↗
“As of December 31, 2025, the material weakness had been remediated. Although we have remediated this material weakness, investor perceptions of our company may suffer as a result of this previous material weakness”
Filings read
- 10-Q · 2026-11-05read
- 8-K · 2026-10-22read
- 10-Q · 2026-07-30queued
- 10-Q · 2026-05-05queued
- 10-K · 2026-02-26queued
- 10-Q · 2025-11-06queued
- 8-K · 2025-10-22queued
- 10-Q · 2025-08-07queued
- 10-Q · 2025-05-07queued
- 10-K · 2025-02-27queued
- 8-K · 2025-01-24queued
- 8-K · 2025-01-10queued
- 8-K · 2024-11-15queued
Think something here is wrong? Request a correction. Open corrections hide the affected disclosure until resolved.